NCT01159704

Brief Summary

Using a randomized clinical trial (RCT), this study is designed to assess the effectiveness of HIV (human immunodeficiency virus) risk-reduction interventions targeting injection drug users (IDUs) in three Ukraine oblasts (regions). The investigators propose to compare the effectiveness of a revised and updated manually-driven HIV testing and counseling intervention, the Counseling and Education (C \& E) model developed by NIDA, with the C \& E plus a manualized network intervention. At each site, Odessa, Donetsk and Nikolayev, 250 "index members" and 500 of their network members will be recruited through street outreach over a 32-month period and randomly assigned to C \& E alone or C \& E plus the network intervention. Participants will be tested for drug metabolites, interviewed using ACASI (Audio Computer-Assisted Self-Interviewing), and given a rapid test for HIV at baseline, 6 and 12-months. At six-months, network members will be asked to recruit two others they inject with but who are not in the study. Primary outcomes include knowledge, self-efficacy, injection and sex-related risk behavior reduction and partner disclosure among indexes and primary and secondary network members and intervention diffusion to secondary network members. The investigators hypothesize more positive and significant change, including injection and sex risk reduction, intervention diffusion, and partner disclosure, among indexes as well as first and second network members in the network plus C \& E arm compared to C \& E alone. Specific aims include:

  1. 1.To compare the effectiveness of the C \& E alone with the additive effect of a network intervention plus C \& E in increasing knowledge about HIV and increasing self-efficacy to practice safer injection and sex-related behaviors among indexes, primary and secondary network members.
  2. 2.To assess the effectiveness of the C \& E alone with the additive effect of a network intervention plus C \& E in reducing drug and sex risk behaviors among indexes, primary and secondary network members.
  3. 3.To compare the extent of intervention diffusion to second wave network members in the two arms.
  4. 4.To evaluate the extent of disclosure by HIV positive indexes and network members in the two arms

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,304

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 8, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 9, 2010

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

June 19, 2019

Status Verified

June 1, 2019

Enrollment Period

5.3 years

First QC Date

July 8, 2010

Last Update Submit

June 17, 2019

Conditions

Keywords

HIV infectionInterventionRisk-reductionInjection drug users

Outcome Measures

Primary Outcomes (5)

  • HIV Knowledge

    Follow-up interviews at 6 and 12 months

  • Self-efficacy regarding HIV risk reduction

    Follow-up interviews at 6 and 12 months

  • Injection risk behavior reduction

    Follow-up interviews at 6 and 12 months

  • Sex-related risk behavior reduction

    Follow-up interviews at 6 and 12 months

  • Intervention diffusion to secondary network members

    Follow-up interviews at 6 and 12 months

Study Arms (2)

Network plus HIV Counseling&Education

EXPERIMENTAL

Social network peer education model plus HIV testing and counseling; the C \& E intervention is a manualized individual-level model consisting of two education and counseling sessions that "structurally bracket confidential HIV antibody screening."

Behavioral: Peer Education ModelBehavioral: HIV Counseling and Education Model

HIV Counseling and Education (C&E) only

ACTIVE COMPARATOR

HIV testing and counseling C\&E; the C \& E intervention is a manualized individual-level model consisting of two education and counseling sessions that "structurally bracket confidential HIV antibody screening."

Behavioral: HIV Counseling and Education Model

Interventions

The peer education intervention will be delivered by trained outreach workers in a group format with 8-10 indexes over five sessions spanning three weeks. The sessions will focus on knowledge of HIV transmission, self-efficacy and skills-building regarding HIV risk reduction, with an emphasis on the dissemination of such information and skills to network members.

Network plus HIV Counseling&Education

The C \& E intervention is a manualized individual-level model consisting of two education and counseling sessions that "structurally bracket confidential HIV antibody screening."

HIV Counseling and Education (C&E) onlyNetwork plus HIV Counseling&Education

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • active drug injector
  • years of age or older
  • not too intoxicated to give informed consent
  • not planning to leave the area in the next 6 months and no pending court date that might result in incarceration
  • agree to HIV testing and counseling
  • not involved in prior project research activities in teh previous 24 months
  • Indexes: must be able to recruit two eligible network members into the study
  • Network: agree to participate in five peer educator training sessions

You may not qualify if:

  • being too intoxicated at the time of the interview
  • impaired mentally due to physical or psychological problems to the point that they cannot voluntarily consent to participate in the study and/or respond to the interview
  • have a known reason why they will not be available for the intervention or the follow-up interview
  • have been involved in prior project research activities in the previous 24 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

NGO

Donetsk, Ukraine

Location

NGO

Nikolayev, Ukraine

Location

NGO

Odesa, Ukraine

Location

Related Publications (1)

  • Booth RE, Davis JM, Dvoryak S, Brewster JT, Lisovska O, Strathdee SA, Latkin CA. HIV incidence among people who inject drugs (PWIDs) in Ukraine: results from a clustered randomised trial. Lancet HIV. 2016 Oct;3(10):e482-9. doi: 10.1016/S2352-3018(16)30040-6. Epub 2016 Jul 29.

MeSH Terms

Conditions

HIV InfectionsRisk Reduction Behavior

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesBehavior

Study Officials

  • Robert Booth, PhD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2010

First Posted

July 9, 2010

Study Start

July 1, 2010

Primary Completion

November 1, 2015

Study Completion

March 1, 2017

Last Updated

June 19, 2019

Record last verified: 2019-06

Locations